Canadian Pharmacy Blog

Bananas may be the next candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) in developing countries. In the forthcoming June 1 issue of Biotechnology Progress, co-published by the American Chemical Society and the American Institute of Chemical Engineers, researchers in India review the efforts to genetically engineer plants as biofactories for vaccine [...]

HepaGam B (Cangene, Canada) has been approved for the prevention of hepatitis B re-infection in certain liver transplant recipients. HepaGam B is made from human plasma from healthy donors in the U.S. Liver transplant patients who have previously been exposed to the hepatitis B virus (HBV) are at an increased risk of re-infection because they [...]